November 15, 2026 · American heart journal · DOI: 10.1016/j.ahj.2026.107659

Inflammation and the Association of Early-stage Cardiovascular-Kidney-Metabolic Syndrome with Incident Cardiovascular Disease and All-cause Mortality: Findings from the CARDIA and MESA Cohorts.

Listen to this summary

This study used data from 9,894 CVD-free adults in the CARDIA and MESA cohorts to test whether inflammation, measured by IL-6 (primary) and hsCRP (secondary), modifies the link between early-stage cardiovascular-kidney-metabolic (CKM) syndrome (stages 2-3 vs 0-1) and incident atherosclerotic CVD, heart failure, and all-cause mortality. Higher IL-6 was independently associated with greater risk of all three outcomes, and it showed additive (but not multiplicative) interaction with CKM stage for atherosclerotic CVD, with hsCRP showing no consistent modification. Overall, the findings suggest that elevated IL-6 may compound cardiovascular risk among adults with early-stage CKM syndrome, though effect modification was limited to one outcome and one measure of interaction.

Ling Tian, Thanh Huyen T Vu, David R Jacobs, Pamela J Schreiner, Nilay S Shah, Cora E Lewis, Sadiya S Khan, Ankeet Bhatt, John T Wilkins, Norrina B Allen, Donald M Lloyd-Jones, Philip Greenland, Laura J Rasmussen-Torvik, Mercedes R Carnethon, Matthew J Feinstein

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play